Explore more publications!
Product Innovation Times
Got News to Share?

Press Releases

Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying
8 hours ago

Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

Indeterminate GlobeNewswire, Inc.
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
10 hours ago

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

Indeterminate GlobeNewswire, Inc.
ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE
11 hours ago

ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE

Indeterminate GlobeNewswire, Inc.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX
15 hours ago

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

Indeterminate GlobeNewswire, Inc.
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
15 hours ago

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

Indeterminate GlobeNewswire, Inc.
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
18 hours ago

Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire, Inc.
CORT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT
Apr. 18, 2026

CORT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class Action – CORT

Indeterminate GlobeNewswire, Inc.
VigoSurge Claims Evaluated: Analyzing the Ingredients' Benefits, Side Effects Risk and Customer Complaints
Apr. 18, 2026

VigoSurge Claims Evaluated: Analyzing the Ingredients' Benefits, Side Effects Risk and Customer Complaints

Indeterminate GlobeNewswire, Inc.
Trial Lawyer Jason Stephens Featured in ‘Blind Spots’ WFAA/TEGNA News Truck Safety Investigation
Apr. 17, 2026

Trial Lawyer Jason Stephens Featured in ‘Blind Spots’ WFAA/TEGNA News Truck Safety Investigation

Indeterminate GlobeNewswire, Inc.
Terra Innovatum Provides Update on Annual Report Filing Process
Apr. 17, 2026

Terra Innovatum Provides Update on Annual Report Filing Process

Indeterminate GlobeNewswire, Inc.
Aussie Select Wins Food Innovation Award at F&B@Sea Awards 2026, Recognizing Breakthrough in Lamb Charcuterie
Apr. 17, 2026

Aussie Select Wins Food Innovation Award at F&B@Sea Awards 2026, Recognizing Breakthrough in Lamb Charcuterie

Neutral EIN Presswire
KBL Advisors Highlights Vision and Process for Scalable Product Development
Apr. 17, 2026

KBL Advisors Highlights Vision and Process for Scalable Product Development

Neutral EIN Presswire
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
Apr. 17, 2026

HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany

Indeterminate GlobeNewswire, Inc.
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
Apr. 17, 2026

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

Indeterminate GlobeNewswire, Inc.
Rodeo Realty’s Jesse James Johnston Presents Veteran-Owned Barbershop & Retail Property in Canoga Park
Apr. 17, 2026

Rodeo Realty’s Jesse James Johnston Presents Veteran-Owned Barbershop & Retail Property in Canoga Park

Neutral EIN Presswire
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Apr. 17, 2026

Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial

Indeterminate GlobeNewswire, Inc.
UBestmall LIMITED Launches Its Fully Upgraded 2026 Platform, Leading the Cryptocurrency Shopping Revolution
Apr. 17, 2026

UBestmall LIMITED Launches Its Fully Upgraded 2026 Platform, Leading the Cryptocurrency Shopping Revolution

Indeterminate GlobeNewswire, Inc.
China International Consumer Products Expo 2026 Underway in Haikou with Over 3,400 Brands
Apr. 17, 2026

China International Consumer Products Expo 2026 Underway in Haikou with Over 3,400 Brands

Indeterminate GlobeNewswire, Inc.
Axalta Earns Three 2026 Edison Awards™ for Innovations in Automotive Customization, Electric Vehicle Safety, and AI-Powered Color Technology
Apr. 17, 2026

Axalta Earns Three 2026 Edison Awards™ for Innovations in Automotive Customization, Electric Vehicle Safety, and AI-Powered Color Technology

Indeterminate GlobeNewswire, Inc.
MIRhosting strengthens internal expertise in GDPR, compliance and customer due diligence
Apr. 17, 2026

MIRhosting strengthens internal expertise in GDPR, compliance and customer due diligence

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions